Analytical Data
-
Gene name
MG281
- Application
-
Alternative Names
/
-
Species
Mycoplasma genitalium
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P47523
-
Expression Region
74-468aa
-
Molecular Weight
50.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MG281, a recombinant protein, has garnered significant attention in the field of molecular biology and biomedicine due to its potential applications in therapeutic and diagnostic modalities. This protein is derived from the MG281 gene, which encodes for a protein implicated in various cellular mechanisms, including immune responses and signal transduction pathways. Researchers are particularly interested in MG281 because of its potential role in modulating immune responses in diseases such as cancer and autoimmune disorders. The ability to produce MG281 in a recombinant form allows for in-depth studies of its structure-function relationships, as well as its interactions with other biomolecules. Furthermore, understanding the biochemical properties and biological functions of MG281 could lead to innovative approaches in drug development and targeted therapies. Recent advancements in biotechnology have facilitated the production and purification of MG281, allowing for extensive research into its effects on immune cells and other relevant biological systems. As scientists continue to explore the functional implications of MG281, its potential as a biomarker or therapeutic target remains a focal point, highlighting the need for ongoing research in this area. Ultimately, the elucidation of MG281's role in health and disease could pave the way for new strategies in the treatment of various medical conditions, underscoring its significance in contemporary scientific inquiry.
